16 Oct 2018

DRUGMAKERS FUNNEL MILLIONS TO LAWMAKERS; A FEW DOZEN GET $100,000-PLUS

  By Emmarie Huetteman and Sydney Lupkin Before the midterm elections heated up, dozens of drugmakers had already poured about $12 million into the war chests of hundreds of members of Congress. Since the beginning of last year, 34 lawmakers have each received more than $100,000 from pharmaceutical companies. Two

0
16 Oct 2018

TELEMEDICINE GIANT HEALTHRIGHT, 4 COMPOUNDING PHARMACIES CHARGED WITH $1 BILLION FRAUD

  HealthRight CEO Scott Roix of the telemedicine company HealthRight pleaded guilty to felony conspiracy charges brought by the Department of Justice. Roix and the company also pleaded guilty to conspiring to commit wire fraud associated with a telemarketing scheme to sell dietary supplements, skin creams and testosterone to patients. Roix and the

0
09 Oct 2018

CMS ANNOUNCES PARTICIPANTS IN NEW VALUE-BASED BUNDLED PAYMENT MODEL

  On Oct. 9, the Centers for Medicare & Medicaid Services (CMS) announced that 1,299 entities have signed agreements with the agency to participate in the Administration’s Bundled Payments for Care Improvement – Advanced (BPCI Advanced) Model.  The participating entities will receive bundled payments for certain episodes of care as

0
28 Sep 2018

SEEMA VERMA SPEECH: CMS TO BEGIN AUDITS ON MEDICAID INSURERS

Seema Verma, Centers for Medicare & Medicaid Services Administrator, issued a warning to Medicaid plan sponsors on Thursday, warning the agency would begin unscheduled targeted financial audits. The warning came at the 2018 Medicaid Managed Care Summit during a speech Verma delivered in which she vowed to bring more transparency to

0
29 Aug 2018

MEDICAL GROUPS, PATIENT ADVOCATES OPPOSE MEDICARE PLANS TO CONSOLIDATE E/M CODES

More than 150 medical groups sent a letter opposing a government plan to consolidate evaluation and management (E/M) codes, saying it could underpay doctors who treat the sickest patients. In a letter sent to Seema Verma, administrator of the Centers for Medicare & Medicaid Services, the groups — including the American Medical Association

0
13 Aug 2018

ENOUGH IS ENOUGH: MEDICAL GROUPS DEMAND HHS STOP STALLING ON INFORMATION BLOCKING

                Enough is enough. The American Academy of Family Physicians (AAFP) joined 13 other medical associations and healthcare organizations Aug. 9 in telling the federal government it has dragged out the regulation-writing process on an important topic far too long. At issue are the information blocking provisions of the 21st Century

0
10 Aug 2018

GLOBAL ULTRASOUND DEVICES MARKET ANALYZED THROUGH 2023

           A global ultrasound devices market report has added to the Research and Markets  offering. According to the “Global Ultrasound Devices Market — Segmented by Application, Technology, Type, and Geography – Growth, Trends, and Forecast (2018-2023)” report, the market is expected to register a CAGR of about 4 percent during 2018-2023. The

0
08 Aug 2018

MEDICAL GROUPS SEE PROGRESS IN CMS’s EHR APPROACH IN HOSPITAL RULE

Medical groups have applauded steps that the Centers for Medicare & Medicaid Services took to ease administrative burden through a new rule on hospital payments, while still pressing the agency for further changes in its approach to electronic health records. On Aug. 2, the CMS unveiled the final version of

0
17 Jul 2018

TELEFLEX TO ACQUIRE QT VASCULAR ASSETS, TAKES OPTION ON CHOCOLATE HEART DCB

QT Vascular has agreed to sell its non-drug coated coronary products to Teleflex, including its Chocolate XD and Glider, with an option to purchase its Chocolate Heart drug-coated coronary balloon catheter which is currently under development. Singapore-based QT Vascular has not released any financial details of the agreement, but said that it

0
17 Jul 2018

SONAVEX RECEIVES FDA CLEARANCE FOR MEDICAL IMAGING DEVICES

Canton, Ohio-based medical device startup Sonavex. A John Hopkin spinout, received clearance from the U.S. Food and Drug Administration to market implantable devices to be used with ultrasound imaging, CEO David Narrow said. The 510(k) clearance means the Johns Hopkins spinout startup has regulatory approval for its initial product. The Echomark devices are designed to

0